Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: tbone0096 who wrote (8082)	10/28/2009 11:05:27 AM
From: gonnahappensoon	Read Replies (1) \| Respond to of 63329

The volume says everything.

To: tbone0096 who wrote (8082)	10/28/2009 11:07:52 PM
From: li3511	Read Replies (1) \| Respond to of 63329

> looks as though small cap bios have fallen out of favor for the meantime. > we are certainly not the only ones getting whacked True. This isn't an anti-Immunomedics market, the whole sector is down. The bubble in biotechs started with HGS's unexpectedly good news, and everyone ran looking for the "next HGSI." What happens if the results released next week are crappy -- if BLISS-52 was an aberration? "Next HGSI" changes meaning to stock that loses 70-90% of its value overnight. It has not been hard to resist the temptation to buy IMMU this week. One has to keep their powder dry for next week.